ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,996.66
      1.00%
      US Tech 100
      20,877.20
      1.72%
      Dow Jones
      43,487.83
      0.78%
      Brent Oil
      79.745
      -0.59%
      Bitcoin
      107,706.29
      4.48%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Hyloris Pharmaceuticals SA (HYL) Quote

      Hyloris Pharmaceuticals SA

      Hyloris Pharmaceuticals SA (HYL)

      EU
      5.60
      0.00
      (0.00%)
      Closed January 20 11:30AM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      5.60
      Bid
      5.80
      Ask
      5.80
      Volume
      0.00
      0.00 Day's Range 0.00
      2.89 52 Week Range 13.30
      Market Cap
      156.8M
      Previous Close
      5.60
      Open
      -
      Last Trade
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      18,243
      Shares Outstanding
      28,000,000
      Dividend Yield
      -
      PE Ratio
      -10.19
      Earnings Per Share (EPS)
      -0.55
      Revenue
      4.21M
      Net Profit
      -15.38M

      About Hyloris Pharmaceuticals SA

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.hyloris.com
      Headquarters
      Liege, Liege, Bel
      Founded
      -
      Hyloris Pharmaceuticals SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker HYL. The last closing price for Hyloris Pharmaceuticals was 5.60 €. Over the last year, Hyloris Pharmaceuticals shares have traded in a share price range of 2.89 € to 13.30 €.

      Hyloris Pharmaceuticals currently has 28,000,000 shares outstanding. The market capitalization of Hyloris Pharmaceuticals is 156.80 € million. Hyloris Pharmaceuticals has a price to earnings ratio (PE ratio) of -10.19.

      Ask ADVFN Intelligence (AI)

      HYL Latest News

      More News

      Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives

      Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives Le total des produits et autres revenus atteint 4,4...

      March 14 2024
      GlobeNewswire Inc.

      Communiqué à la requête de la FSMA sur les transactions avec QliniQ

      Communiqué à la requête de la FSMA sur les transactions avec QliniQ Communiqué à la requête de la FSMA sur les transactions avec QliniQ Retraitement des états financiers de 2022 et de juin...

      March 14 2024
      GlobeNewswire Inc.

      Hyloris to Report 2023 Full-Year Results on 14 March 2024

      Hyloris to Report 2023 Full-Year Results on 14 March 2024 Liège, Belgium – 08 February 2024, 07:00 AM CET – Non-regulated information – Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a...

      March 08 2024
      GlobeNewswire Inc.

      Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada

      Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada Maxigesic® IV, a Potent Non-opioid...

      February 27 2024
      GlobeNewswire Inc.

      Hyloris Recrute un Premier Patient dans le Cadre d'un Essai Clinique de Phase 3 portant sur son Rince-Bouche Breveté Destiné à Contrôler les Saignements lors des Interventions Dentaires

      Hyloris Recrute un Premier Patient dans le Cadre d'un Essai Clinique de Phase 3 portant sur son Rince-Bouche Breveté Destiné à Contrôler les Saignements lors des Interventions Dentaires...

      February 14 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.48-7.894736842116.086.085.628825.84869613DE
      40.387.279693486595.227.265.2213286.32907627DE
      12-0.22-3.780068728525.827.263.06182435.5691239DE
      26-6.1-52.136752136811.711.72.89224975.710289DE
      52-7.4-56.92307692311313.32.89142177.08521496DE
      156-11.65-67.536231884117.2517.52.8981709.82198656DE
      260-5.15-47.906976744210.7519.12.89941910.94295351DE

      HYL - Frequently Asked Questions (FAQ)

      What is the current Hyloris Pharmaceuticals share price?
      The current share price of Hyloris Pharmaceuticals is 5.60 €
      How many Hyloris Pharmaceuticals shares are in issue?
      Hyloris Pharmaceuticals has 28,000,000 shares in issue
      What is the market cap of Hyloris Pharmaceuticals?
      The market capitalisation of Hyloris Pharmaceuticals is EUR 156.8M
      What is the 1 year trading range for Hyloris Pharmaceuticals share price?
      Hyloris Pharmaceuticals has traded in the range of 2.89 € to 13.30 € during the past year
      What is the PE ratio of Hyloris Pharmaceuticals?
      The price to earnings ratio of Hyloris Pharmaceuticals is -10.19
      What is the cash to sales ratio of Hyloris Pharmaceuticals?
      The cash to sales ratio of Hyloris Pharmaceuticals is 37.21
      What is the reporting currency for Hyloris Pharmaceuticals?
      Hyloris Pharmaceuticals reports financial results in EUR
      What is the latest annual turnover for Hyloris Pharmaceuticals?
      The latest annual turnover of Hyloris Pharmaceuticals is EUR 4.21M
      What is the latest annual profit for Hyloris Pharmaceuticals?
      The latest annual profit of Hyloris Pharmaceuticals is EUR -15.38M
      What is the registered address of Hyloris Pharmaceuticals?
      The registered address for Hyloris Pharmaceuticals is BOULEVARD PATIENCE ET BEAUJONC, LIEGE, LIEGE, 4000
      What is the Hyloris Pharmaceuticals website address?
      The website address for Hyloris Pharmaceuticals is www.hyloris.com
      Which industry sector does Hyloris Pharmaceuticals operate in?
      Hyloris Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ABCAABC Arbitrage
      4.805 €
      (0.00%)
      		0
      ABAb Science
      1.75 €
      (0.00%)
      		0
      AALBAalberts NV
      34.20 €
      (0.00%)
      		0
      AAAAlan Allman Associates
      7.35 €
      (0.00%)
      		0
      74SW74Software SA
      27.10 €
      (0.00%)
      		0
      ABCAABC Arbitrage
      4.805 €
      (0.00%)
      		0
      ABAb Science
      1.75 €
      (0.00%)
      		0
      AALBAalberts NV
      34.20 €
      (0.00%)
      		0
      AAAAlan Allman Associates
      7.35 €
      (0.00%)
      		0
      74SW74Software SA
      27.10 €
      (0.00%)
      		0
      ABCAABC Arbitrage
      4.805 €
      (0.00%)
      		0
      ABAb Science
      1.75 €
      (0.00%)
      		0
      AALBAalberts NV
      34.20 €
      (0.00%)
      		0
      AAAAlan Allman Associates
      7.35 €
      (0.00%)
      		0
      74SW74Software SA
      27.10 €
      (0.00%)
      		0

      Discussion

      View Full Feed
      Iggy_Bot Iggy_Bot 7 minutes ago
      So they are sticking things in front of him, telling'
      him they are something else ?
      TommyJ7651 TommyJ7651 7 minutes ago
      Yes, for sure any potential buyer must know that Keith would immediately counter with a better offer if they tried to do a hostile takeover. In almost all interviews you always hear Keith stating he is a very long term investor and that is simply the reality of investing in miners. Mining CEO's have
      FFMGF
      weedtrader420 weedtrader420 8 minutes ago
      🧠WEEEEEEEEEEEEEEEEEE
      BTCUSD
      weedtrader420 weedtrader420 10 minutes ago
      WOOHOOOOOOOOOOOOOOO
      BTCUSD
      JamesLH JamesLH 12 minutes ago
      🤡🤡🤡🤡🤡🤡🤡🤡🤡🤡🤡
      SNPW
      BDEZ BDEZ 18 minutes ago
      U see this yet? https://x.com/WallStreetApes/status/1881033029382193613
      BDEZ BDEZ 19 minutes ago
      For sure...
      ATDS FB CULT ATDS FB CULT 21 minutes ago
      Anyone else watching this history live,?
      Haven't watched a squeeze live like that in long time. Fun fun fun
      Looks like lucky 1's are coming right up
      BTCUSD
      Sheepdog Sheepdog 23 minutes ago
      "This board" was first started in July of 2018.

      Should be an easy check before posting BS, right?
      .
      GCAN
      BDEZ BDEZ 25 minutes ago
      Karen Bass history https://x.com/RealJamesWoods/status/1880769377110552691
      BDEZ BDEZ 27 minutes ago
      We are being played https://x.com/WallStreetApes/status/1880834013067149780
      BDEZ BDEZ 29 minutes ago
      U see this kid? https://x.com/QueenAnticommie/status/1881170030592958882
      BDEZ BDEZ 30 minutes ago
      Thanks for sharing...
      knrorrel knrorrel 39 minutes ago
      AWESOME ❤️
      JTBK
      knrorrel knrorrel 42 minutes ago
      SOUNDS GREAT
      JTBK
      igotthemojo igotthemojo 46 minutes ago
      "Companies that employ a tactic to avoid delisting by destroying value SHOULD BE a crime (which were my exact words)"

      no...those were not your exact words...these were your exact words:

      "A company that defrauds investors like that should be sued and delisted."
      FCEL
      joeycav11 joeycav11 54 minutes ago
      Flipper you have to have faith that management knows what they are doing. Approval allows promotion and advertising of DCVax. A new revolutionary product.
      People and companies will be fighting to be associated with this paridigm shift.
      What I see happening is news flow coming out sl
      NWBO
      JoeForkeyBolo JoeForkeyBolo 56 minutes ago
      Jeff Weber's method of using AIM with LEAPs rolls over the options annually, with the LEAPs being rolled over have expirations about 1 year away, and are exchanged for LEAPs having expirations 2 years away. The time decay in the last 6 months prior to expiration should have no impact on Weber's meth
      QQQ
      SuperStream852 SuperStream852 56 minutes ago
      It sounds like you're using humor and metaphor to express frustration with a situation where you're losing money, but you don't believe the source is the pants themselves. Instead, you're hinting at external factors or entities that might be influencing the situation, potentially in a way that seems
      PTOI
      holter49 holter49 57 minutes ago
      I hope you are correct and we do sky.
      MLRT
      KILLAZILLA KILLAZILLA 1 hour ago
      LOLOLOLOL....

      YET, STILL DOWN OVER 80%....

      GOOD JOB. BETTER THAN DONE 90%....

      UNFORTUNATELY, WHEN THIS POS SCAM GETS DELISTED OR GOES DARK, NO MORE HOPE!!!!
      XERI
      amelia43 amelia43 1 hour ago
      Market is closed tomorrow. MLK
      FNMA
      Steady_T Steady_T 1 hour ago
      I don't use Think or Swim. I loaded it and worked with it for a few days and decided I didn't care for it. From the TOS search page...
      Tick Charts
      Tick charts represent the count of intraday trades: a new bar (or candlestick, line section, etc.) is plotted after completion of a certain
      NWBO

      Your Recent History

      EU
      HYL
      Hyloris Pharmaceuticals
      LSE
      74LI
      Higher Ed.1 B2a
      TG
      UIMA
      UBS Lux Fund Solutions M...
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads